These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
589 related articles for article (PubMed ID: 20454659)
21. Rosuvastatin inhibit spheroid formation and epithelial-mesenchymal transition (EMT) in prostate cancer PC-3 cell line. Deezagi A; Safari N Mol Biol Rep; 2020 Nov; 47(11):8727-8737. PubMed ID: 33085048 [TBL] [Abstract][Full Text] [Related]
22. Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery. Fontana F; Raimondi M; Marzagalli M; Sommariva M; Gagliano N; Limonta P Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948069 [TBL] [Abstract][Full Text] [Related]
23. Type 1 insulin-like growth factor regulates MT1-MMP synthesis and tumor invasion via PI 3-kinase/Akt signaling. Zhang D; Brodt P Oncogene; 2003 Feb; 22(7):974-82. PubMed ID: 12592384 [TBL] [Abstract][Full Text] [Related]
24. Saposin C promotes survival and prevents apoptosis via PI3K/Akt-dependent pathway in prostate cancer cells. Lee TJ; Sartor O; Luftig RB; Koochekpour S Mol Cancer; 2004 Nov; 3():31. PubMed ID: 15548330 [TBL] [Abstract][Full Text] [Related]
25. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway. Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871 [TBL] [Abstract][Full Text] [Related]
26. Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3-kinase-mediated Akt signaling. Liu K; Park C; Chen H; Hwang J; Thimmegowda NR; Bae EY; Lee KW; Kim HG; Liu H; Soung NK; Peng C; Jang JH; Kim KE; Ahn JS; Bode AM; Dong Z; Kim BY; Dong Z Mol Carcinog; 2015 Sep; 54(9):751-60. PubMed ID: 24700667 [TBL] [Abstract][Full Text] [Related]
27. Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten-/-TP53-/- prostate cancer model. Abou-Kheir WG; Hynes PG; Martin PL; Pierce R; Kelly K Stem Cells; 2010 Dec; 28(12):2129-40. PubMed ID: 20936707 [TBL] [Abstract][Full Text] [Related]
28. 3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases. Xie Z; Yuan H; Yin Y; Zeng X; Bai R; Glazer RI BMC Cancer; 2006 Mar; 6():77. PubMed ID: 16551362 [TBL] [Abstract][Full Text] [Related]
29. Epithelial-To-Mesenchymal Transition Markers and CD44 Isoforms Are Differently Expressed in 2D and 3D Cell Cultures of Prostate Cancer Cells. Fontana F; Raimondi M; Marzagalli M; Sommariva M; Limonta P; Gagliano N Cells; 2019 Feb; 8(2):. PubMed ID: 30754655 [TBL] [Abstract][Full Text] [Related]
30. Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis. Neuwirt H; Bouchal J; Kharaishvili G; Ploner C; Jöhrer K; Pitterl F; Weber A; Klocker H; Eder IE Cell Commun Signal; 2020 Jan; 18(1):11. PubMed ID: 31980029 [TBL] [Abstract][Full Text] [Related]
31. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
32. Metastatic renal cell carcinoma cells growing in 3D on poly‑D‑lysine or laminin present a stem‑like phenotype and drug resistance. Brodaczewska KK; Bielecka ZF; Maliszewska-Olejniczak K; Szczylik C; Porta C; Bartnik E; Czarnecka AM Oncol Rep; 2019 Nov; 42(5):1878-1892. PubMed ID: 31545459 [TBL] [Abstract][Full Text] [Related]
33. Involvement of PI3K/Akt pathway in prostate cancer--potential strategies for developing targeted therapies. Pommery N; Hénichart JP Mini Rev Med Chem; 2005 Dec; 5(12):1125-32. PubMed ID: 16375758 [TBL] [Abstract][Full Text] [Related]
35. BMS-777607, a small-molecule met kinase inhibitor, suppresses hepatocyte growth factor-stimulated prostate cancer metastatic phenotype in vitro. Dai Y; Siemann DW Mol Cancer Ther; 2010 Jun; 9(6):1554-61. PubMed ID: 20515943 [TBL] [Abstract][Full Text] [Related]
36. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer. Ma T; Chen H; Wang P; Yang N; Bao J Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162 [No Abstract] [Full Text] [Related]
37. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis. Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980 [TBL] [Abstract][Full Text] [Related]
38. Dual PI3 K/mTOR inhibition reduces prostate cancer bone engraftment altering tumor-induced bone remodeling. Mancini A; Colapietro A; Pompili S; Del Fattore A; Delle Monache S; Biordi LA; Angelucci A; Mattei V; Liang C; Gravina GL; Festuccia C Tumour Biol; 2018 Apr; 40(4):1010428318771773. PubMed ID: 29687745 [TBL] [Abstract][Full Text] [Related]
39. Novel library of selenocompounds as kinase modulators. Plano D; Ibáñez E; Calvo A; Palop JA; Sanmartín C Molecules; 2011 Jul; 16(8):6349-64. PubMed ID: 21796074 [TBL] [Abstract][Full Text] [Related]
40. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP). Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]